Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995

by Louis P. Galambos, Jane Eliot Sewell (Contributor)

Networks of Innovation offers a historical perspective on the manner in which private sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp & Dohme, which acquired Mulford in 1929, and on Merck & Co., Inc., which merged with Sharp & Dohme in 1953. By surveying a century of innovation in biologicals, the authors show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad.

288 pages, Paperback

First published January 1, 1995

About the author

The former editor of the 21-volume Papers of Dwight David Eisenhower, Louis Paul Galambos is professor emeritus in history and at Johns Hopkins University, where he has worked since 1971. Galambos earned a B.A. in history (1955) from Indiana University, an M.A. in history (1957) and Ph.D. (1960) from Yale University. He previously served as an Assistant Professor (1960-1966), Associate Professor (1966-1969), and Professor (1969-1970) at Rice University, as well as Professor (1970-1971) at Rutgers University.